U.S. Anesthesia Partners Leads a Changing Industry by Preparing the Next Generation for the Future of Anesthesia
By Neal Grabarkewitz Every September, a select group of physician residents and student nurse anesthetists...
Editorial
Reformation Reports Double-Digit Income & Revenue Growth
By Karen Roman Reformation Inc. (NYSE: REF) said net revenue rose 24.1% to $155.2 million...
VERAXA Biotech Designates Raju Willener as CFO
By Karen Roman Veraxa Biotech AG (Nasdaq: VRXA) said it appointed Raju Willener as Chief...
Lands’ End New CEO Agenda, Customer Growth – Quarterly Update Report
Download the Complete Report Here Lands’ End, Inc. (LE) Fulfilment Normalizes as New CEO Sets...
REX’s Record 2Q EPS, CCS Project Advances – Quarterly Update Report
Download the Complete Report Here REX American Resources Corp. (REX) Record Second Quarter Driven by...
Caesarstone’s Premium Multi-Material & Differentiated Model Proposition – Initiation Report
Download the Complete Report Here Caesarstone Ltd. (CSTE) Multi-Material Expansion and Margin Recovery Support the...
Apple v. OpenAI: Governance Lessons in Trade Secret Protection from Both Sides of the “V”
By Mary Guzman Apple’s July 10, 2026 lawsuit against OpenAI, filed in the Northern District...
Chris Benecchi Named Inventiva’s New Chief Operating Officer
By Karen Roman Inventiva S.A. (Nasdaq: IVA) said it designated Chris Benecchi as Chief Operating...
Cocrystal Pharma: The Strategic Reset Investors May Be Missing
By Mike Sheikh Cocrystal Pharma (NASDAQ: COCP) may look like another undercapitalized, clinical-stage biotech searching for...
Slate Medicines Starts Migraine Treatment Study
By Karen Roman Slate Medicines Inc. said it dosed the first participant in Phase 1...
© Copyright 2025, ExecEdge